 |
The Journal of Neuroscience, January 14, 2004, 24(2):508-513; doi:10.1523/JNEUROSCI.4386-03.2004
Previous Article | Next Article 
Neurobiology of Disease
Dysregulated IP3 Signaling in Cortical Neurons of Knock-In Mice Expressing an Alzheimer's-Linked Mutation in Presenilin1 Results in Exaggerated Ca2+ Signals and Altered Membrane Excitability
Grace E. Stutzmann,
Antonella Caccamo,
Frank M. LaFerla, and
Ian Parker
Department of Neurobiology and Behavior, University of California, Irvine, Irvine, California 92697-4550
Disruptions in intracellular Ca2+ signaling are proposed to underlie the pathophysiology of Alzheimer's disease (AD), and it has recently been shown that AD-linked mutations in the presenilin 1 gene (PS1) enhance inositol triphosphate (IP3)-mediated Ca2+ liberation in nonexcitable cells. However, little is known of these actions in neurons, which are the principal locus of AD pathology. We therefore sought to determine how PS1 mutations affect Ca2+ signals and their subsequent downstream effector functions in cortical neurons. Using whole-cell patch-clamp recording, flash photolysis, and two-photon imaging in brain slices from 4-5-week-old mice, we show that IP3-evoked Ca2+ responses are more than threefold greater in PS1M146V knock-in mice relative to age-matched nontransgenic controls. Electrical excitability is thereby reduced via enhanced Ca2+ activation of K+ conductances. Action potential-evoked Ca2+ signals were unchanged, indicating that PS1M146V mutations specifically disrupt intracellular Ca2+ liberation rather than reduce cytosolic Ca2+ buffering or clearance. Moreover, IP3 receptor levels are not different in cortical homogenates, further suggesting that the exaggerated cytosolic Ca2+ signals may result from increased store filling and not from increased flux through additional IP3-gated channels. Even in young animals, PS1 mutations have profound effects on neuronal Ca2+ and electrical signaling: cumulatively, these disruptions may contribute to the long-term pathophysiology of AD.
Key words: Alzheimer; calcium [Ca]; cortex; imaging; patch clamp; pyramidal; inositol triphosphate
Received Sep 26, 2003;
revised November 24, 2003;
accepted November 25, 2003.
This article has been cited by other articles:

|
 |

|
 |
 
K. M. Park, D. I. Yule, and W. J. Bowers
Tumor Necrosis Factor-{alpha}-mediated Regulation of the Inositol 1,4,5-Trisphosphate Receptor Promoter
J. Biol. Chem.,
October 2, 2009;
284(40):
27557 - 27566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chakroborty, I. Goussakov, M. B. Miller, and G. E. Stutzmann
Deviant Ryanodine Receptor-Mediated Calcium Release Resets Synaptic Homeostasis in Presymptomatic 3xTg-AD Mice
J. Neurosci.,
July 29, 2009;
29(30):
9458 - 9470.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. N. Green, A. Demuro, Y. Akbari, B. D. Hitt, I. F. Smith, I. Parker, and F. M. LaFerla
SERCA pump activity is physiologically regulated by presenilin and regulates amyloid {beta} production
J. Cell Biol.,
October 22, 2008;
181(7):
1107 - 1116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Liang, Q. Wang, Y. Li, B. Kang, M. F. Eckenhoff, R. G. Eckenhoff, and H. Wei
A Presenilin-1 Mutation Renders Neurons Vulnerable to Isoflurane Toxicity
Anesth. Analg.,
February 1, 2008;
106(2):
492 - 500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Rengifo, C. J. Gibson, E. Winkler, T. Collin, and B. E. Ehrlich
Regulation of the Inositol 1,4,5-Trisphosphate Receptor Type I by O-GlcNAc Glycosylation
J. Neurosci.,
December 12, 2007;
27(50):
13813 - 13821.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E. Stutzmann
The Pathogenesis of Alzheimers Disease Is It a Lifelong "Calciumopathy"?
Neuroscientist,
October 1, 2007;
13(5):
546 - 559.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
B. L. Kelly and A. Ferreira
beta-Amyloid-induced Dynamin 1 Degradation Is Mediated by N-Methyl-D-Aspartate Receptors in Hippocampal Neurons
J. Biol. Chem.,
September 22, 2006;
281(38):
28079 - 28089.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. S. Oh and R. J. Turner
Effect of {gamma}-secretase inhibitors on muscarinic receptor-mediated calcium signaling in human salivary epithelial cells
Am J Physiol Cell Physiol,
July 1, 2006;
291(1):
C76 - C82.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Cai, P. Lin, K.-H. Cheung, N. Li, C. Levchook, Z. Pan, C. Ferrante, G. L. Boulianne, J. K. Foskett, D. Danielpour, et al.
The Presenilin-2 Loop Peptide Perturbs Intracellular Ca2+ Homeostasis and Accelerates Apoptosis
J. Biol. Chem.,
June 16, 2006;
281(24):
16649 - 16655.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E. Stutzmann, I. Smith, A. Caccamo, S. Oddo, F. M. LaFerla, and I. Parker
Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice.
J. Neurosci.,
May 10, 2006;
26(19):
5180 - 5189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Cook, X. Li, S. D. Cherry, and A. R. Cantrell
Presenilin 1 Deficiency Alters the Activity of Voltage-Gated Ca2+ Channels in Cultured Cortical Neurons
J Neurophysiol,
December 1, 2005;
94(6):
4421 - 4429.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Demuro, E. Mina, R. Kayed, S. C. Milton, I. Parker, and C. G. Glabe
Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers
J. Biol. Chem.,
April 29, 2005;
280(17):
17294 - 17300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E. Stutzmann
Calcium Dysregulation, IP3 Signaling, and Alzheimer's Disease
Neuroscientist,
April 1, 2005;
11(2):
110 - 115.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Verkhratsky
Physiology and Pathophysiology of the Calcium Store in the Endoplasmic Reticulum of Neurons
Physiol Rev,
January 1, 2005;
85(1):
201 - 279.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|